|Chemical and physical data|
|Molar mass||194.954 g/mol|
|3D model (JSmol)|
Halopropane (synonym FHD-3, trade name Tebron) is a halocarbon drug which was investigated as an inhalational anesthetic but was never marketed. Its clinical development was terminated due to a high incidence of cardiac arrhythmias in patients, similarly to the cases of teflurane and norflurane.
- Nigel R. Webster; Helen F. Galley (22 August 2013). Landmark Papers in Anaesthesia. OUP Oxford. pp. 70–. ISBN 978-0-19-163319-5.
- Acta anaesthesiologica Belgica. Acta Medica Belgica. 1974.
- Sanford L. Klein (1993). A glossary of anesthesia and related terminology. Springer-Verlag. ISBN 978-0-387-97831-4.
- Earl J. Catcott; J. F. Smithcors (1973). Progress in canine practice. American Veterinary Publications.
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|